Research Paper Volume 16, Issue 10 pp 8944—8964
SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
Figure 15. SLAMF8 expression is related to immune and molecular subtypes in pan-cancers. (A–D) The correlation between SLAMF8 expression and pan-cancer molecular subtypes. (E–H) The correlation between SLAMF8 expression and pan-cancer immune subtypes. Note: C1 (wound healing); C2 (IFN-gamma dominant); C3 (inflammatory); C4 (lymphocyte depleted); C5 (immunologically quiet); C6 (TGF-b dominant).